da Vinci Surgery
 

Treatments & Surgical Options for Cancer

Gynecologic cancers can affect a woman's reproductive system, which consists of the uterus, vagina, ovaries and fallopian tubes. The uterus is a hollow, muscular organ that holds a baby as it grows inside a pregnant woman. The fallopian tubes and ovaries are located on either side of the uterus.

The most common types of gynecologic cancers are cervical, endometrial (uterine) and ovarian cancer. The specific type of cancer a woman has and how advanced it is, will determine her treatment and surgical options.

Women with early stage gynecologic cancer often have a hysterectomy - the surgical removal of the uterus. In this procedure, the doctor may also remove the ovaries, fallopian tubes and/or select lymph nodes.

Hysterectomy is the second most common surgical procedure for women in the U.S., and an estimated one third of all U.S. women will have a hysterectomy by age 60.1

Learn more:

PN 1002236 Rev B 01/2014

Important Safety Information

Serious complications may occur in any surgery, including da Vinci® Surgery, up to and including death. Individual surgical results may vary. Patients should talk to their doctor to decide if da Vinci Surgery is right for them. Patients and doctors should review all available information on non-surgical and surgical options in order to make an informed decision. Please also refer to http://www.daVinciSurgery.com/Safety for Important Safety Information.

When Is Single-Site Technology Used and What Are the Risks?

da Vinci Surgery with Single-Site® Instruments is cleared for use in gallbladder removal, and for hysterectomy and ovary removal for benign conditions. Patients who are not candidates for non-robotic minimally invasive surgery are also not candidates for da Vinci Surgery, including da Vinci Surgery with Single-Site Instruments. There may be an increased risk of incision-site hernia with single-incision surgery, including Single-Site surgery with the da Vinci System. Single-Site® Instruments for the da Vinci® Si System bear the CE mark. This device is cleared for commercial distribution in the U.S. for laparoscopic cholecystectomy, and for hysterectomy and salpingo-oophorectomy for benign conditions.

© 2015 Intuitive Surgical, Inc. All rights reserved. Product names are trademarks or registered trademarks of their respective holders.

* Important Patient Safety Information.

Hysterectomy for Cancer



Considering Hysterectomy?


Patient Testimonial

Use this player for all videos on dVS.com English.